https://telixpharma.com/investors/
Telix reports total revenue of $22.5 million from global sales of Illuccix® in its first commercial quarter – more than a ten-fold increase on the previous quarter ($1.9 million, Q1 2022). This includes USD$13.6 million (AUD$19.3 million) generated from sales of Illuccix in the United States in the ten weeks following first commercial sales.
https://telixpharma.com/investors/Telix reports total revenue of...
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.44 |
Change
-0.320(1.54%) |
Mkt cap ! $6.840B | |||
| Open | High | Low | Value | Volume |
| $20.79 | $21.00 | $20.22 | $19.41M | 945.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $20.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.46 | 45 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| TLX (ASX) Chart |